SGN-CD19A

· Seagen Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SGN-CD19A, covering 2017-07-02 to 2017-10-19. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study of SGN-CD19A for B-Cell Lymphoma [Phase 1]